These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 25233414

  • 1. Signalling specificity in the Akt pathway in breast cancer.
    Clark AR, Toker A.
    Biochem Soc Trans; 2014 Oct; 42(5):1349-55. PubMed ID: 25233414
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases.
    Rodgers SJ, Ferguson DT, Mitchell CA, Ooms LM.
    Biosci Rep; 2017 Feb 28; 37(1):. PubMed ID: 28082369
    [Abstract] [Full Text] [Related]

  • 4. Distinct functional roles of Akt isoforms for proliferation, survival, migration and EGF-mediated signalling in lung cancer derived disseminated tumor cells.
    Grabinski N, Bartkowiak K, Grupp K, Brandt B, Pantel K, Jücker M.
    Cell Signal; 2011 Dec 28; 23(12):1952-60. PubMed ID: 21777670
    [Abstract] [Full Text] [Related]

  • 5. Upregulated WDR26 serves as a scaffold to coordinate PI3K/ AKT pathway-driven breast cancer cell growth, migration, and invasion.
    Ye Y, Tang X, Sun Z, Chen S.
    Oncotarget; 2016 Apr 05; 7(14):17854-69. PubMed ID: 26895380
    [Abstract] [Full Text] [Related]

  • 6. AKT isoforms 1 and 3 regulate basal and epidermal growth factor-stimulated SGHPL-5 trophoblast cell migration in humans.
    Haslinger P, Haider S, Sonderegger S, Otten JV, Pollheimer J, Whitley G, Knöfler M.
    Biol Reprod; 2013 Mar 05; 88(3):54. PubMed ID: 23303682
    [Abstract] [Full Text] [Related]

  • 7. [Akt kinase: a key regulator of metabolism and progression of tumors].
    Krześlak A.
    Postepy Hig Med Dosw (Online); 2010 Oct 19; 64():490-503. PubMed ID: 20966507
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway.
    Meng Q, Xia C, Fang J, Rojanasakul Y, Jiang BH.
    Cell Signal; 2006 Dec 19; 18(12):2262-71. PubMed ID: 16839745
    [Abstract] [Full Text] [Related]

  • 10. Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway.
    Polivka J, Janku F.
    Pharmacol Ther; 2014 May 19; 142(2):164-75. PubMed ID: 24333502
    [Abstract] [Full Text] [Related]

  • 11. Ang II-AT1R increases cell migration through PI3K/AKT and NF-κB pathways in breast cancer.
    Zhao Y, Wang H, Li X, Cao M, Lu H, Meng Q, Pang H, Li H, Nadolny C, Dong X, Cai L.
    J Cell Physiol; 2014 Nov 19; 229(11):1855-62. PubMed ID: 24692224
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma.
    Ewald F, Grabinski N, Grottke A, Windhorst S, Nörz D, Carstensen L, Staufer K, Hofmann BT, Diehl F, David K, Schumacher U, Nashan B, Jücker M.
    Int J Cancer; 2013 Nov 19; 133(9):2065-76. PubMed ID: 23588885
    [Abstract] [Full Text] [Related]

  • 14. Pathway-based identification of biomarkers for targeted therapeutics: personalized oncology with PI3K pathway inhibitors.
    Andersen JN, Sathyanarayanan S, Di Bacco A, Chi A, Zhang T, Chen AH, Dolinski B, Kraus M, Roberts B, Arthur W, Klinghoffer RA, Gargano D, Li L, Feldman I, Lynch B, Rush J, Hendrickson RC, Blume-Jensen P, Paweletz CP.
    Sci Transl Med; 2010 Aug 04; 2(43):43ra55. PubMed ID: 20686178
    [Abstract] [Full Text] [Related]

  • 15. Akt isoform-specific inhibition of MDA-MB-231 cell proliferation.
    Yang W, Ju JH, Lee KM, Shin I.
    Cell Signal; 2011 Jan 04; 23(1):19-26. PubMed ID: 20688159
    [Abstract] [Full Text] [Related]

  • 16. PI3K/Akt signaling in osteosarcoma.
    Zhang J, Yu XH, Yan YG, Wang C, Wang WJ.
    Clin Chim Acta; 2015 Apr 15; 444():182-92. PubMed ID: 25704303
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The Akt kinases: isoform specificity in metabolism and cancer.
    Gonzalez E, McGraw TE.
    Cell Cycle; 2009 Aug 15; 8(16):2502-8. PubMed ID: 19597332
    [Abstract] [Full Text] [Related]

  • 19. Dissecting signalling by individual Akt/PKB isoforms, three steps at once.
    Osorio-Fuentealba C, Klip A.
    Biochem J; 2015 Sep 01; 470(2):e13-6. PubMed ID: 26348913
    [Abstract] [Full Text] [Related]

  • 20. An AKT2-specific nanobody that targets the hydrophobic motif induces cell cycle arrest, autophagy and loss of focal adhesions in MDA-MB-231 cells.
    Merckaert T, Zwaenepoel O, Gevaert K, Gettemans J.
    Biomed Pharmacother; 2021 Jan 01; 133():111055. PubMed ID: 33378961
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.